P&G Focuses On Consumer Health, “Deemphasizes” Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm considers divesting some or all its four key pharmaceutical brands and will no longer invest in pharma R&D, CEO Lafley says.